Beijing GoBroad Hospital is a research hospital with a focus on diagnosing and treating challenging and critical cases,conducting clinical research,and strategically transforming the industries of biomedicine and medical devices.It serves as a public service platform for clinical research in Beijing.We have gathered a group of renowned clinical research experts in China,along with a complete clinical research support team.Building on its clinical research capabilities,the hospital integrates the strengths of Beijing's rich foundation in basic research,entrepreneurial enterprises,and research institutions to create a high-level ecosystem for medical innovation.

 

The hospital is located in Changping Life Science Park in Beijing,covering an approximate floor area of 100,000 square meters.It is planned to have 500 beds,including 100 beds dedicated to early-stage research.Specializing in solid tumors,hematologic tumors,and brain science,the hospital officially opened in July 2023.

 

Beijing GoBroad Hospital is an explorer and practitioner of the research hospital pattern,serving as one of the flagship hospitals within the GoBroad Healthcare Group which established in 2017,comprises four major business sectors:the Center for Challenging and Critical Care Medicine,Clinical Research Center,Precision Diagnosis Center,and Data Intelligence Center.With a mission to drive medical innovation,the group has gathered renowned clinical experts and built an integrated platform for industry and clinical collaboration.

 

More than half of the team focuses on providing professional services for clinical innovation transformation.Specialized service teams include the Early Clinical Research Center,Central Laboratory,Imaging Center,Pathology Center,Clinical Evaluation Center for Cardiac Safety,Clinical Pharmacology,Medical and Statistical teams,among others.Since its establishment,the group has experienced rapid development,having accumulated a wealth of experience in serving hundreds of innovative pharmaceutical companies and conducting numerous trials.It has also brought new hope to tens of thousands of challenging and critical patients.